574 Stock Overview
An investment holding company, engages in the pharmaceutical distribution and manufacturing business in the People’s Republic of China. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 2/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
Rewards
Risk Analysis
+ 1 more risk
My Notes
Capture your thoughts, links and company narrative
Pa Shun International Holdings Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | HK$0.047 |
| 52 Week High | HK$0.095 |
| 52 Week Low | HK$0.028 |
| Beta | 0.18 |
| 1 Month Change | -14.55% |
| 3 Month Change | 14.63% |
| 1 Year Change | 51.61% |
| 3 Year Change | -24.19% |
| 5 Year Change | -60.83% |
| Change since IPO | -96.69% |
Recent News & Updates
Subdued Growth No Barrier To Pa Shun International Holdings Limited (HKG:574) With Shares Advancing 27%
Dec 04
Revenues Working Against Pa Shun International Holdings Limited's (HKG:574) Share Price Following 30% Dive
Sep 02Pa Shun International Holdings Limited's (HKG:574) Business And Shares Still Trailing The Industry
Jun 04Recent updates
Subdued Growth No Barrier To Pa Shun International Holdings Limited (HKG:574) With Shares Advancing 27%
Dec 04Revenues Working Against Pa Shun International Holdings Limited's (HKG:574) Share Price Following 30% Dive
Sep 02Pa Shun International Holdings Limited's (HKG:574) Business And Shares Still Trailing The Industry
Jun 04Pa Shun International Holdings Limited (HKG:574) Shares May Have Slumped 33% But Getting In Cheap Is Still Unlikely
Feb 18Investors Aren't Buying Pa Shun International Holdings Limited's (HKG:574) Revenues
Dec 19Is Pa Shun International Holdings (HKG:574) Using Debt In A Risky Way?
Apr 05Pa Shun International Holdings (HKG:574) Has Debt But No Earnings; Should You Worry?
Sep 05Is Pa Shun International Holdings (HKG:574) Using Too Much Debt?
May 24Read This Before Selling Pa Shun International Holdings Limited (HKG:574) Shares
Dec 15
Shareholder Returns
| 574 | HK Healthcare | HK Market | |
|---|---|---|---|
| 7D | 6.8% | 0.9% | 1.1% |
| 1Y | 51.6% | -20.9% | 17.6% |
Return vs Industry: 574 exceeded the Hong Kong Healthcare industry which returned -20.9% over the past year.
Return vs Market: 574 exceeded the Hong Kong Market which returned 17.6% over the past year.
Price Volatility
| 574 volatility | |
|---|---|
| 574 Average Weekly Movement | 14.9% |
| Healthcare Industry Average Movement | 8.4% |
| Market Average Movement | 8.5% |
| 10% most volatile stocks in HK Market | 17.8% |
| 10% least volatile stocks in HK Market | 3.9% |
Stable Share Price: 574's share price has been volatile over the past 3 months compared to the Hong Kong market.
Volatility Over Time: 574's weekly volatility (15%) has been stable over the past year, but is still higher than 75% of Hong Kong stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2011 | 90 | Qinghai Ma | www.pashun.com.cn |
Pa Shun International Holdings Limited, an investment holding company, engages in the pharmaceutical distribution and manufacturing business in the People’s Republic of China. The company’s Pharmaceutical Distribution segment sells pharmaceutical products to wholesalers, hospitals, and other medical institutions in rural areas. Its Pharmaceutical Manufacturing segment sells pharmaceutical products manufactured by the company.
Pa Shun International Holdings Limited Fundamentals Summary
| 574 fundamental statistics | |
|---|---|
| Market cap | HK$66.37m |
| Earnings (TTM) | HK$35.37m |
| Revenue (TTM) | HK$101.49m |
2.0x
P/E Ratio0.7x
P/S RatioIs 574 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 574 income statement (TTM) | |
|---|---|
| Revenue | CN¥95.43m |
| Cost of Revenue | CN¥76.73m |
| Gross Profit | CN¥18.70m |
| Other Expenses | -CN¥14.56m |
| Earnings | CN¥33.26m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.023 |
| Gross Margin | 19.59% |
| Net Profit Margin | 34.85% |
| Debt/Equity Ratio | -56.7% |
How did 574 perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/31 12:14 |
| End of Day Share Price | 2024/12/31 00:00 |
| Earnings | 2024/06/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Pa Shun International Holdings Limited is covered by 1 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Ka Lok Yuen | Emperor Securities Limited |